Ra Medical Systems, Inc. (RMED): Price and Financial Metrics

Ra Medical Systems, Inc. (RMED)

Today's Latest Price: $0.32 USD

0.03 (-8.67%)

Updated Aug 12 6:40pm

Add RMED to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

RMED Stock Summary

  • With a one year PEG ratio of 0.16, Ra Medical Systems Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 3.59% of US stocks.
  • RMED's went public 1.88 years ago, making it older than merely 3.81% of listed US stocks we're tracking.
  • In terms of volatility of its share price, RMED is more volatile than 92.66% of stocks we're observing.
  • Stocks that are quantitatively similar to RMED, based on their financial statements, market capitalization, and price volatility, are CDLX, WBAI, CNET, GHSI, and AACG.
  • RMED's SEC filings can be seen here. And to visit Ra Medical Systems Inc's official web site, go to www.ramed.com.
RMED Daily Price Range
RMED 52-Week Price Range

RMED Stock Price Chart Technical Analysis Charts

RMED Price/Volume Stats

Current price $0.32 52-week high $2.69
Prev. close $0.35 52-week low $0.28
Day low $0.31 Volume 9,512,700
Day high $0.33 Avg. volume 2,576,861
50-day MA $0.46 Dividend yield N/A
200-day MA $1.10 Market Cap 4.39M

Ra Medical Systems, Inc. (RMED) Company Bio

RA Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is based in Carlsbad, California.

RMED Latest News Stream

Event/Time News Detail
Loading, please wait...

RMED Latest Social Stream

Loading social stream, please wait...

View Full RMED Social Stream

Latest RMED News From Around the Web

Below are the latest news stories about Ra Medical Systems Inc that investors may wish to consider to help them evaluate RMED as an investment opportunity.

Ra Medical Systems prices upsized public offering

Ra Medical Systems ([[RMED]] -10.9%) priced public offering of 34.3M shares, along with its accompanying warrants, at $0.35/share; gross proceeds of ~$12M.Warrants, immediately exercisable, have an exercise price of $0.35/share; five years expiry from issuance date.Offering is expected to close on or about August 3, 2020.Proceeds will be used for...

Seeking Alpha | July 30, 2020

Ra Medical Systems Announces Pricing of $12.0 Million Upsized Public Offering

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (“Ra Medical”) (NYSE: RMED), a commercial-stage medical device company leveraging its advanced excimer laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases, today announced that it has priced a public offering of an aggregate of 34,285,714 shares of common stock (or common stock equivalents), together with accompanying warrants to purchase up to an aggregate of 34,285,714 sh

Business Wire | July 30, 2020

The Law Offices of Frank R. Cruz Announces Investigation of Ra Medical Systems, Inc. (RMED)

LOS ANGELES--(BUSINESS WIRE)---- $RMED #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Ra Medical Systems, Inc. (“Ra Medical” or the “Company”) (NYSE: RMED) concerning whether the board breached its fiduciary duty to shareholders. If you are a shareholder, click here for more information. Follow us for updates on Twitter: twitter.com/FRC_LAW. If you purchased Ra Medical securities, have information or would like to learn more about these claims, or ha

Business Wire | June 24, 2020

RA MEDICAL INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ra Medical Systems, Inc. - RMED

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Ra Medical Systems, Inc. (NYSE: RMED).

Yahoo | June 20, 2020

Ra Medical Systems Announces Closing of $10.0 Million Public Offering

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems completes $10 million financing.

Business Wire | May 22, 2020

Read More 'RMED' Stories Here

RMED Price Returns

1-mo -25.18%
3-mo -58.85%
6-mo -84.83%
1-year -78.38%
3-year N/A
5-year N/A
YTD -71.68%
2019 -85.79%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.9037 seconds.